Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback

Cynthia Timmers1, Nidhi Sharma, Rene Opavsky

  • 1Human Cancer Genetics program, Department of Molecular Virology, Immunology and Medical Genetics, and Comprehensive Cancer Center, The Ohio State University, 410 W. 12th Avenue, Columbus, OH 43210, USA.

Molecular and Cellular Biology
|December 15, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucagon-Like Peptide-1 Receptor Agonists in Breast Cancer: Metabolic, Clinical, and Survivorship Implications.

JCO oncology practice·2026
Same author

MRI and Clinical Features of Nonenhancing <i>IDH</i>-Wild-Type Glioblastomas: How to Make an Early Diagnosis and Distinguish from Mimics.

AJNR. American journal of neuroradiology·2026
Same author

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Treatment of Adults With WHO Grade II Diffuse Glioma: Update.

Neurosurgery·2026
Same author

Intelligent histology for tumor neurosurgery.

Neuro-oncology advances·2026
Same author

Management of glioblastoma intramedullary spinal cord metastasis with advanced intraoperative techniques: a case series and systematic review.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

EZH2 Inhibition Reshapes 3D Chromatin Architecture to Induce Immunogenic Phenotype in Small Cell Lung Cancer.

bioRxiv : the preprint server for biology·2026
Same journal

ZRANB1 and ACSS2 Cooperate to Regulate Ubiquitination and Acetylation to Stabilize TWIST1 in Breast Cancer Metastasis.

Molecular and cellular biology·2026
Same journal

Gasdermin D Inhibition Attenuates Mitochondrial Damage and Cardiomyocyte Pyroptosis in Heart Failure with Preserved Ejection Fraction.

Molecular and cellular biology·2026
Same journal

Dual Sub‑MIC Copper-Gentamicin Stress Drives Strain‑Specific, Non‑Additive Phenotypic Shifts in <i>Pseudomonas aeruginosa</i>.

Molecular and cellular biology·2026
Same journal

Transcription Factors in Breast Cancer Oncogenesis and Progression.

Molecular and cellular biology·2026
Same journal

Aberrant Expression of miR-25-3p/EZH2 Is Involved in T Cell Activation in Aplastic Anemia.

Molecular and cellular biology·2026
Same journal

Characterization of the m<sup>6</sup>A Epitranscriptome in Fibroblast Senescence.

Molecular and cellular biology·2026
See all related articles
This summary is machine-generated.

Disrupting E2F1, E2F2, and E2F3 activators in mouse cells activates p53, blocking cell proliferation. Restoring p53 function rescues proliferation, revealing a p53-dependent control of E2F activity.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • E2F transcription factors regulate cell cycle progression.
  • E2F activators (E2f1, E2f2, E2f3) are crucial for cellular proliferation.
  • The interplay between E2F and p53 in cell cycle control is complex.

Purpose of the Study:

  • To investigate the role of E2F1, E2F2, and E2F3 activators in cellular proliferation.
  • To elucidate the mechanism by which E2F activators control cell cycle progression.
  • To determine the involvement of p53 in the E2F-mediated proliferation pathway.

Main Methods:

  • Conditional gene targeting in mouse embryonic fibroblasts.
  • Disruption of E2f1, E2f2, and E2f3 genes.
  • Analysis of p53 activation and p53 target gene induction.

Related Experiment Videos

  • Assessment of cyclin-dependent kinase activity and retinoblastoma (Rb) phosphorylation.
  • Inactivation of p53 via spontaneous mutation or conditional gene ablation.

    • Main Results:

    • Targeted disruption of E2f1, E2f2, and E2f3 activated p53 and its target genes, including p21(CIP1).
    • This led to inhibition of cyclin-dependent kinase activity and Rb phosphorylation, causing a proliferation block.
    • Inactivation of p53 in E2F-deficient cells restored normal cell cycle progression and E2F target gene expression.

    Conclusions:

    • E2F1, E2F2, and E2F3 activators control a p53-dependent pathway.
    • This pathway indirectly regulates E2F-mediated transcriptional repression.
    • The findings highlight a critical role for E2F activators in controlling cellular proliferation via p53.